Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Streamex Corp. Director's Dealing 2017

Feb 9, 2017

35540_dirs_2017-02-09_17ee3158-fc56-49c3-a1ed-6aa58dbbd412.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BioSig Technologies, Inc. (BSGM)
CIK: 0001530766
Period of Report: 2016-12-22

Reporting Person: ZELDIS JEROME B (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-12-22 Options to Purchase Common Stock $1.36 A 50000 Acquired 2026-12-22 Common Stock (50000) Direct